What is Omnicell?
Founded in 1992, Omnicell is a global healthcare technology company specializing in advanced medication and supply management solutions. The company leverages automation systems, sophisticated software, and comprehensive services to enhance patient safety, boost operational efficiency, and ensure regulatory compliance for healthcare organizations. Omnicell's extensive product portfolio includes automated dispensing cabinets, powerful analytics platforms, medication adherence tools, robotic dispensing systems, and cutting-edge supply management technologies. These offerings are meticulously designed to minimize medication errors, streamline clinical workflows, and optimize inventory control across diverse healthcare environments such as hospitals, retail pharmacies, and long-term care facilities. By integrating seamlessly with hospital information systems, Omnicell's technology fosters a holistic medication management ecosystem, supporting healthcare providers worldwide in their mission to deliver exceptional patient care.
How much funding has Omnicell raised?
Omnicell has raised a total of $62M across 2 funding rounds:
Other Financing Round
$20M
Stock Offering
$42M
Other Financing Round (2000): $20M with participation from ABS Capital Partners, Sutter Hill Ventures, and Nassau Capital
Stock Issuance/Offering (2001): $42M, investors not publicly disclosed
Key Investors in Omnicell
ABS Capital Partners
ABS Capital Partners is a growth equity firm that partners with technology-enabled services companies to accelerate their expansion and build scalable business models. They focus on B2B software and tech-enabled services, providing capital and strategic guidance to companies with strong technology foundations.
Sutter Hill Ventures
Sutter Hill Ventures is a venture capital firm based in Palo Alto, California, that specializes in financing technology start-ups and assisting entrepreneurs in building market-leading companies. They offer extensive operating and venture capital experience, along with strong industry networks.
What's next for Omnicell?
The recent major strategic investment signals a pivotal growth phase for Omnicell. This capital infusion is expected to accelerate the company's expansion into new markets, further enhance its research and development initiatives for next-generation healthcare automation, and potentially facilitate strategic acquisitions. Omnicell's focus on improving patient safety and operational efficiency through technology positions it favorably to capitalize on the increasing demand for integrated healthcare management solutions. The company's trajectory suggests a continued emphasis on innovation and market leadership within the critical healthcare technology landscape.
See full Omnicell company page
